Providing optimal care for patients with diabetic eye disease

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

The authors evaluated shallow irregular pigment epithelial detachment, subretinal hyperreflective material, subretinal fluid, intraretinal fluid and other baseline OCT biomarkers

Researchers screened for outcomes such as the presence of retinal diseases including age-related macular degeneration and retinal vein occlusion